A Study to Evaluate the Safety and Efficacy of WS016 in Patients With Hyperkalemia.
Clinical trial NCT06277128 · UNKNOWN
Trial details
- NCT number
- NCT06277128
- Sponsor
- Waterstone Pharmaceutical (Wuhan) Co., LTD.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-11
- Primary completion
- 2024-04-18
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.